Photodynamic Therapy of Cholangiocarcinoma Cancer - 17/07/18
Doi : 10.1016/S1052-5157(18)30117-X
Maria-Anna E.J. Ortner, MD ⁎ 
From the Endoscopy Unit, Department of Gastroenterology/Hepatology/Endocrinology, Humboldt University Charité CCN, Berlin, Germany
*Address reprint requests to: Maria-Anna E. J. Ortner, MD, Department of Gastroenterology/Hepatology/Endocrinology, Humboldt University Charité CCN, Schumannstrasse 20-21, D-10117 Berlin, GermanyDepartment of Gastroenterology/Hepatology/EndocrinologyHumboldt University Charité CCNSchumannstrasse 20-21BerlinD-10117Germany
Résumé |
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors relief of jaundice is seldom achieved, despite successful endoprosthesis insertion. Additional photodynamic therapy seems to be a promising new approach to these tumors. First pilot studies show relief of jaundice, mainly because of opening of the intrahepatic ducts and improvements in quality of life indices. Survival time seems to be long; however, randomized studies are necessary to confirm these results.
Le texte complet de cet article est disponible en PDF.© 2000
Elsevier Inc. Tous droits réservés.
Vol 10 - N° 3
P. 481-486 - juillet 2000 Retour au numéro
Article précédent
- Photodynamic Therapy of Gastric Cancer
- Liebwin Gossner, Christian Ell
- Complications of Photodynamic Therapy in Gastrointestinal Disease
- Kenneth K. Wang, Pardeep K. Nijhawan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?